Condition
Carcinoma, Pancreatic Ductal|Mesothelioma|Ovarian Neoplasms|Carcinoma, Non-Small-Cell Lung
Estimated Enrollment: 7
Age Group: 18 Years to 100 Years (Adult, Senior)
Gender: All
Study Type: Interventional
Study Design Allocation: Allocation: Non-Randomized|Intervention Model: Single Group Assignment|Primary Purpose: Treatment
Study ID Numbers: 110212|11-C-0212
Study First Received: August 9, 2011
Last Updated: April 19, 2017
Estimated Primary Completion Date: November 15, 2013
Primary Outcome Measures:
Biodistribution of radiolabelled amatuximab in tumor and nontumor tissues.|Tumor|Background ratio of maximum counts|CTCAE V.4 events|Observation of HACA|PKs|Antibody uptake vs. IHC mesothelin expression
Sponsors and Collaborators:
National Cancer Institute (NCI)|National Institutes of Health Clinical Center (CC)
Website Link: https://ClinicalTrials.gov/show/NCT01413451
